![]() |
|
|
Vol. 292, Issue 2, 761-768, February 2000
Expression
Department of Pharmacology, Hokkaido University School of Medicine,
Sapporo, Japan.
The purpose of this study was to determine the mechanism responsible
for alterations in NaF-induced contractions of blood vessels from
streptozotocin-induced diabetic rats. In the presence of
AlCl3, NaF (
7.5 mM) produced significantly greater
contractions in diabetic aorta and mesenteric artery compared with
age-matched controls. Pretreatment with 1 µM nifedipine eliminated
the enhanced contractile responses of diabetic vessels to NaF,
resulting in no difference in the magnitude of NaF-induced contractions
between control and diabetic vessels. In the presence of 100 µM
deferoxamine, an Al3+ chelator, NaF-induced contractions of
diabetic vessels were markedly attenuated, whereas only the responses
to lower concentrations of NaF were reduced in control vessels. No
significant difference was found in the peak amplitude of transient
contractions induced by 10 µM cyclopiazonic acid between control and
diabetic vessels. The addition of 10 µM okadaic acid produced
attenuated contractions in diabetic vessels. These findings indicate no
involvement of the inhibitory effects of NaF on endoplasmic reticular
Ca2+-pump ATPase and protein phosphatases in the genesis of
the enhanced responsiveness of diabetic vessels to NaF. Western blot
analysis showed a 2.5-fold increase in the expression of
Gq
in diabetic aortic membranes. In contrast, the
Gi
level was modestly decreased and the
Gs
and G
levels were unchanged in
diabetes. The present results suggest that enhanced vascular contractions to NaF in diabetes is attributed predominantly to a G
protein-mediated Ca2+ channel activation that results from
markedly increased Gq
expression in vascular tissues
under this pathological state.
This article has been cited by other articles:
![]() |
P. Wang, A. D. Verin, A. Birukova, L. I. Gilbert-McClain, K. Jacobs, and J. G. N. Garcia Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1472 - L1483. [Abstract] [Full Text] [PDF] |
||||